Key Highlights

  • LKQ shares are trading up 5.63% at $19.61, against a previous close of $18.56.
  • Third-quarter Revenue of about $3.3 billion fell 5.1%, with an $88 million specialty Goodwill impairment.
  • Adjusted diluted EPS was $0.50 against $0.84 a year earlier, with GAAP diluted EPS at a loss of $0.09.
  • Free Cash Flow was $372 million, and the company prepaid a $500 million term loan.
  • Full-year 2026 guidance was withdrawn, and the strategic review was paused.

LKQ (NASDAQ:LKQ) shares are rebounding as investors weigh a messy third quarter against signs of operational stabilization and a reset narrative. Chicago-based LKQ is a global distributor of vehicle replacement parts, components and systems, with about 44,000 employees and operations across North America, Europe and Specialty segments. Shares are recovering from a selloff that followed the Oct. 23 CEO departure.

Leadership Change, Withdrawn Guidance and a Paused Review

LKQ named a new president and CEO effective Dec. 15, replacing the prior CEO, who left Oct. 23. An interim Office of the CEO is in place. The board also changed European leadership, engaged a consulting firm to stabilize operations and suspended the strategic review, including the specialty sales process. Full-year 2026 guidance was suspended and should no longer be relied upon.

Third-Quarter Results Weighed by Charges

Revenue of about $3.3 billion, down 5.1%, was below the $3.4 billion estimate, with organic revenue down 5.4%. Adjusted EPS of $0.50 compared with an estimate of $0.48. GAAP diluted EPS was a loss of $0.09 against $0.69 a year ago, including $111 million of pre-tax non-cash charges: an $88 million specialty goodwill Impairment and a $23 million Romania held-for-sale impairment.

Europe Weakens While North America Margins Expand

European organic revenue fell 9.8% and segment EBITDA was $68 million, a 4.6% Margin versus 10.0%. A German ERP disruption cost about $95 million of revenue and $43 million of EBITDA. German sales are about 85% of the prior year, on-time in-full delivery has recovered to about 95%, and execution issues caused share loss in the UK and Benelux. Management plans more aggressive pricing and customer incentives in the fourth quarter.

North America organic revenue fell 2.4%, against repairable claims down 1% to 3%. EBITDA was $203 million at a 14.4% margin, up 40 basis points, with gross margin at 42.3% and alternative part utilization at a record above 41%. Specialty organic revenue grew 0.9%, but EBITDA was $25 million at a 5.5% margin, down 180 basis points.

Cash Flow, Leverage and Analyst View

Operating cash flow was $411 million, and free cash flow was $372 million. Total Debt was $3.7 billion, leverage was 2.8 times and Liquidity was about $1.7 billion, with no significant maturities until 2028. The company repurchased $30 million of shares, paid $76 million in dividends and declared a $0.30 quarterly dividend.

Barclays has an Overweight rating with a $25 target. The stock trades at 8.86 times forward Earnings with a 6.11% Dividend yield and a market Capitalization of about $4.95 billion. Its 52-week range runs from $16.85 to $37.13, and the shares are down roughly 38% year to date, with law firm investigations noted as an overhang.

Fourth-Quarter Seasonality and European Recovery to Watch

Management expects normal third-to-fourth-quarter seasonality across segments but gave no formal outlook. Investors will watch the European recovery in Germany, North America margins, the CEO transition on Dec. 15 and any new guidance.